Kristin leads the Diagnostics and Life Sciences Practice at Health Advances, a global practice which meshes her consulting and scientific experience to provide results-oriented commercialization strategies for her clients in the biotech and clinical diagnostics sectors, including focus on launch strategy, pricing, and R&D prioritization for novel diagnostics and biotech platforms for the research laboratory, personalized medicine, point-of-care, and mainstream clinical diagnostics. Kristin is a noted speaker, workshop leader and writer in the diagnostics and life sciences industries, covering topics such as the future of point-of-care platforms, the commercialization of companion diagnostics, and innovations in personalized medicine. She is also a founder of DxInsights, a non-profit organization designed to educate on the impact of diagnostics in improving healthcare outcomes to the nation's healthcare communities.
Kristin has over 16 years of experience in the diagnostics and drug discovery industries. Prior to joining Health Advances in 2002, Kristin was a scientist in diagnostics technology development at Genzyme and genomics research at Genome Therapeutics. She has an undergraduate degree in Biochemistry from Smith College and a Masters degree in Epidemiology, Health Management, and Maternal and Child Health from the Harvard School of Public Health.